Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

334 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients.
Paya C, Humar A, Dominguez E, Washburn K, Blumberg E, Alexander B, Freeman R, Heaton N, Pescovitz MD; Valganciclovir Solid Organ Transplant Study Group. Paya C, et al. Among authors: blumberg e. Am J Transplant. 2004 Apr;4(4):611-20. doi: 10.1111/j.1600-6143.2004.00382.x. Am J Transplant. 2004. PMID: 15023154 Free article. Clinical Trial.
Absence of cytomegalovirus-resistance mutations after valganciclovir prophylaxis, in a prospective multicenter study of solid-organ transplant recipients.
Boivin G, Goyette N, Gilbert C, Roberts N, Macey K, Paya C, Pescovitz MD, Humar A, Dominguez E, Washburn K, Blumberg E, Alexander B, Freeman R, Heaton N, Covington E. Boivin G, et al. Among authors: blumberg e. J Infect Dis. 2004 May 1;189(9):1615-8. doi: 10.1086/382753. Epub 2004 Apr 13. J Infect Dis. 2004. PMID: 15116297 Clinical Trial.
Risk factors for cytomegalovirus viremia and disease developing after prophylaxis in high-risk solid-organ transplant recipients.
Freeman RB, Paya C, Pescovitz MD, Humar A, Dominguez E, Washburn K, Blumberg E, Alexander B, Heaton N; Valganciclovir Solid Organ Transplant Study Group. Freeman RB, et al. Among authors: blumberg e. Transplantation. 2004 Dec 27;78(12):1765-73. doi: 10.1097/01.tp.0000142619.01510.a5. Transplantation. 2004. PMID: 15614149 Clinical Trial.
Pharmacodynamics of oral ganciclovir and valganciclovir in solid organ transplant recipients.
Wiltshire H, Paya CV, Pescovitz MD, Humar A, Dominguez E, Washburn K, Blumberg E, Alexander B, Freeman R, Heaton N, Zuideveld KP; Valganciclovir Solid Organ Transplant Study Group. Wiltshire H, et al. Among authors: blumberg e. Transplantation. 2005 Jun 15;79(11):1477-83. doi: 10.1097/01.tp.0000164512.99703.ad. Transplantation. 2005. PMID: 15940035 Clinical Trial.
Pharmacokinetic profile of ganciclovir after its oral administration and from its prodrug, valganciclovir, in solid organ transplant recipients.
Wiltshire H, Hirankarn S, Farrell C, Paya C, Pescovitz MD, Humar A, Dominguez E, Washburn K, Blumberg E, Alexander B, Freeman R, Heaton N; Valganciclovir Solid Organ Transplant Study Group. Wiltshire H, et al. Among authors: blumberg e. Clin Pharmacokinet. 2005;44(5):495-507. doi: 10.2165/00003088-200544050-00003. Clin Pharmacokinet. 2005. PMID: 15871635 Clinical Trial.
Efficacy and safety of maribavir dosed at 100 mg orally twice daily for the prevention of cytomegalovirus disease in liver transplant recipients: a randomized, double-blind, multicenter controlled trial.
Winston DJ, Saliba F, Blumberg E, Abouljoud M, Garcia-Diaz JB, Goss JA, Clough L, Avery R, Limaye AP, Ericzon BG, Navasa M, Troisi RI, Chen H, Villano SA, Uknis ME; 1263-301 Clinical Study Group. Winston DJ, et al. Among authors: blumberg e. Am J Transplant. 2012 Nov;12(11):3021-30. doi: 10.1111/j.1600-6143.2012.04231.x. Epub 2012 Sep 4. Am J Transplant. 2012. PMID: 22947426 Free article. Clinical Trial.
Nucleic acid testing (NAT) of organ donors: is the 'best' test the right test? A consensus conference report.
Humar A, Morris M, Blumberg E, Freeman R, Preiksaitis J, Kiberd B, Schweitzer E, Ganz S, Caliendo A, Orlowski JP, Wilson B, Kotton C, Michaels M, Kleinman S, Geier S, Murphy B, Green M, Levi M, Knoll G, Segev DL, Brubaker S, Hasz R, Lebovitz DJ, Mulligan D, O'Connor K, Pruett T, Mozes M, Lee I, Delmonico F, Fischer S. Humar A, et al. Among authors: blumberg e. Am J Transplant. 2010 Apr;10(4):889-899. doi: 10.1111/j.1600-6143.2009.02992.x. Epub 2010 Jan 29. Am J Transplant. 2010. PMID: 20121734 Free article. Review.
Pulmonary zygomycosis in solid organ transplant recipients in the current era.
Sun HY, Aguado JM, Bonatti H, Forrest G, Gupta KL, Safdar N, John GT, Pursell KJ, Muñoz P, Patel R, Fortun J, Martin-Davila P, Philippe B, Philit F, Tabah A, Terzi N, Chatelet V, Kusne S, Clark N, Blumberg E, Julia MB, Humar A, Houston S, Lass-Florl C, Johnson L, Dubberke ER, Barron MA, Lortholary O, Singh N; Zygomycosis Transplant Study Group. Sun HY, et al. Among authors: blumberg e. Am J Transplant. 2009 Sep;9(9):2166-71. doi: 10.1111/j.1600-6143.2009.02754.x. Epub 2009 Jul 22. Am J Transplant. 2009. PMID: 19681829 Free article.
Response to questions regarding the design and results of the IMPACT trial.
Humar A; IMPACT Investigators Steering Committee; Peeters P, Abramowicz D, Humar A, Lebranchu Y, Hauser I, Jardine A, Limaye AP, Vincenti F, Punch JD, Blumberg E. Humar A, et al. Among authors: blumberg e. Am J Transplant. 2011 Jan;11(1):177-8. doi: 10.1111/j.1600-6143.2010.03370.x. Am J Transplant. 2011. PMID: 21199360 Free article. No abstract available.
334 results